Hojjat Naderi-Meshkin
Overview
Explore the profile of Hojjat Naderi-Meshkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naderi-Meshkin H, Wahyu Setyaningsih W, Yacoub A, Carney G, Cornelius V, Nelson C, et al.
Stem Cells
. 2024 Jul;
42(9):791-808.
PMID: 39049437
Vascular organoids (VOs), derived from induced pluripotent stem cells (iPSCs), hold promise as in vitro disease models and drug screening platforms. However, their ability to faithfully recapitulate human vascular disease...
2.
Naderi-Meshkin H, Setyaningsih W
Front Biosci (Landmark Ed)
. 2024 Jun;
29(6):223.
PMID: 38940049
Endothelial cell dysfunction is a complex process involving various causes, early and late events, and subsequent consequences. This review provides an overview of each aspect and outlines therapeutic interventions targeting...
3.
Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies
Naderi-Meshkin H, Cornelius V, Eleftheriadou M, Potel K, Setyaningsih W, Margariti A
Stem Cell Res Ther
. 2023 Oct;
14(1):292.
PMID: 37817281
Understanding mechanisms and manifestations of cardiovascular risk factors, including diabetes, on vascular cells such as endothelial cells, pericytes, and vascular smooth muscle cells, remains elusive partly due to the lack...
4.
Pun S, ONeill K, Edgar K, Gill E, Moez A, Naderi-Meshkin H, et al.
Cells
. 2023 Sep;
12(18).
PMID: 37759443
Ischaemic cardiovascular disease is associated with tissue hypoxia as a significant determinant of angiogenic dysfunction and adverse remodelling. While cord blood-derived endothelial colony-forming cells (CB-ECFCs) hold clear therapeutic potential due...
5.
Moghimi V, Rahvarian J, Esmaeilzadeh Z, Mohammad-Pour N, Babaki D, Sadeghifar F, et al.
Acta Histochem
. 2023 Apr;
125(3):152027.
PMID: 37062121
Several strategies have been proposed to enhance wound healing results. Along with other forms of wound dressing, the human amniotic membrane (HAM) has long been regarded as a biological wound...
6.
Toosi S, Naderi-Meshkin H, Moradi A, Daliri M, Moghimi V, Majd H, et al.
ACS Biomater Sci Eng
. 2023 Mar;
9(4):1928-1939.
PMID: 36939654
In this study, the procedure for treating the nonunion complication of scaphoid fractures using collagen/poly glycolic acid (CPGA) scaffolds with bone marrow mesenchymal stem cell (BM-MSC) therapy was adopted and...
7.
Mohammad-Pour N, Moghimi V, Bidkhori H, Momeni-Moghaddam M, Naderi-Meshkin H
Int J Low Extrem Wounds
. 2023 Feb;
:15347346231155751.
PMID: 36794512
Off-the-shelf supply of viable engineered tissue is critical for effective and fast treatment of life-threatening injuries such as deep burns. An expanded keratinocyte sheet on the human amniotic membrane (KC...
8.
Amirkhah R, Gilroy K, Malla S, Lannagan T, Byrne R, Fisher N, et al.
Br J Cancer
. 2023 Jan;
128(7):1333-1343.
PMID: 36717674
Background: Colorectal cancer (CRC) primary tumours are molecularly classified into four consensus molecular subtypes (CMS1-4). Genetically engineered mouse models aim to faithfully mimic the complexity of human cancers and, when...
9.
Toosi S, Naderi-Meshkin H, Esmailzadeh Z, Behravan G, Ramakrishna S, Behravan J
Front Bioeng Biotechnol
. 2022 Sep;
10:963996.
PMID: 36159698
Today's using tissue engineering and suitable scaffolds have got attention to increase healing of non-union bone fractures. In this study, we aimed to prepare and characterize scaffolds with functional and...
10.
Cornelius V, Naderi-Meshkin H, Kelaini S, Margariti A
Cells
. 2022 Aug;
11(16).
PMID: 36010571
Vascular diseases account for a significant number of deaths worldwide, with cardiovascular diseases remaining the leading cause of mortality. This ongoing, ever-increasing burden has made the need for an effective...